Lakewood-Amedex Biotherapeutics, Inc. LABT · SEC Filings

website

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develo...

Price0.418

Market Cap995.27 K

Float1.77 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 22, 2026

News

TYPE

HEADLINE

FILED AT

8-K

Lakewood-Amedex Biotherapeutics Inc. Announces Results from 2026 Annual Meeting of Stockholders

Sep 28, 2026

8-K

Lakewood-Amedex Biotherapeutics Investor Deck: Advancing Bisphosphocin® Antimicrobials for iDFU

Jul 15, 2026

8-K

Lakewood-Amedex Biotherapeutics Inc. Announces 1-for-10 Reverse Stock Split

Jun 17, 2026

8-K

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

Apr 28, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Aug 17, 2026

424B3

OFFERING - OTHER

Jun 22, 2026

424B3

UPDATE TO PRIOR PROSPECTUS

Jun 22, 2026

424B3

OFFERING - OTHER

May 26, 2026

424B3

OFFERING - OTHER

May 26, 2026

424B4

SHARE RESALE REGISTRATION | Shares: 9,647,726

May 14, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-1

SHARE RESALE REGISTRATION EFFECTIVE, DATED 2026-09-24

Sep 18, 2026

DRS

Form DRS - Draft Registration Statement

Aug 21, 2026

S-1

SHARE RESALE REGISTRATION

May 1, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Apr 17, 2026

S-1/A

SHARE RESALE REGISTRATION | Shares: 4,689,177

Apr 6, 2026

S-1/A

SHARE RESALE REGISTRATION | Shares: 4,689,177

Apr 1, 2026

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Aug 10, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Aug 10, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Jul 30, 2026

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

WFI Equity, LLC (Filed by)

Aug 14, 2026

SCHEDULE 13G

Lindesfarne LLC (Filed by)

Aug 6, 2026

SCHEDULE 13G

HPW Investments Holding Ltd. (Filed by)

Jun 23, 2026

Tucker Joseph Edward (Reporting)

May 6, 2026

Tucker Joseph Edward (Reporting)

May 6, 2026

DeRoma Leonard James (Reporting)

May 1, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 25, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

May 14, 2026

CORRESP

Form CORRESP - Correspondence

May 12, 2026

LETTER

Form UPLOAD - SEC-generated letter

May 8, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 20, 2026